Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Targeted Oncology|December 11, 2025
Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Phase I/II, Multicenter, Multi-arm StudyAlba Rubio-San-Simón, Lynley V Marshall, Francois Doz, et al.
Lab on a Chip|November 17, 2025
Application of a bioengineered intestinal epithelium for drug permeability and metabolism studiesElisabeth Gill, Stephanie Muenchau Schoepp, Sina Simon, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 18, 2018
Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus InhibitorNicole A Kratochwil, Miriam Triyatni, Martina B Mueller, et al.
ERJ Open Research|August 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthmaMatthew Chad Eastwood, John Busby, Johan Kolmert, et al.
Frontiers in Oncology|April 5, 2024
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposureAnna Spreafico, Eva Muñoz Couselo, Anja Irmisch, et al.
The European Respiratory Journal|September 26, 2015
The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohortsLouise Fleming, Clare Murray, Aruna T Bansal, et al.
Allergy|January 23, 2019
Contribution of airway eosinophils in airway wall remodeling in asthma: Role of MMP-10 and METChih-Hsi S Kuo, Stelios Pavlidis, Jie Zhu, et al.
American Journal of Respiratory and Critical Care Medicine|September 1, 2016
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPREDChih-Hsi Scott Kuo, Stelios Pavlidis, Matthew Loza, et al.
Allergy, Asthma & Immunology Research|August 19, 2024
Comparison of Asthma Phenotypes in Severe Asthma Cohorts (SARP, U-BIOPRED, ProAR and COREA) From 4 ContinentsSo-Young Park, Stephen Fowler, Dominic E Shaw, et al.
American Journal of Respiratory and Critical Care Medicine|April 18, 2024
Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA StudyRatko Djukanović, Paul Brinkman, Johan Kolmert, et al.
Pageof 8